Protagonist Therapeutics, Inc. (PTGX)
90.25
+0.60
(+0.67%)
USD |
NASDAQ |
Dec 08, 16:00
90.22
-0.03
(-0.03%)
After-Hours: 20:00
Protagonist Therapeutics Research and Development Expense (Quarterly): 40.00M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Johnson & Johnson | 3.693B |
| ADMA Biologics, Inc. | 1.528M |
| Regeneron Pharmaceuticals, Inc. | 1.338B |
| Vanda Pharmaceuticals, Inc. | 22.56M |
| Bristol Myers Squibb Co. | 2.433B |